1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine has been researched along with etoposide in 1 studies
| Studies (1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine) | Trials (1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine) | Recent Studies (post-2010) (1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine) | Studies (etoposide) | Trials (etoposide) | Recent Studies (post-2010) (etoposide) |
|---|---|---|---|---|---|
| 22 | 0 | 8 | 18,306 | 3,693 | 4,900 |
| Protein | Taxonomy | 1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine (IC50) | etoposide (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | Homo sapiens (human) | 1.153 | |
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 1.4284 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.187 | |
| Caspase-3 | Homo sapiens (human) | 1 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 0.4299 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 4.18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferracini, M; Sahu, RP; Travers, JB | 1 |
1 other study(ies) available for 1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine and etoposide
| Article | Year |
|---|---|
Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.
Topics: Animals; Antineoplastic Agents; Antioxidants; Etoposide; Female; Immunosuppression Therapy; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction | 2015 |